Aerska Raises €32M to Advance RNA Therapies for Brain Diseases
Irish biotechnology startup Aerska has secured €32 million in new Series A funding to accelerate development of its advanced RNA medicines aimed at treating devastating brain diseases like Alzheimer’s and…